206 related articles for article (PubMed ID: 1550409)
21. Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of ankylosing spondylitis patients with/without iritis and enthesitis.
Mäki-Ikola O; Lehtinen K; Toivanen P; Granfors K
Br J Rheumatol; 1995 May; 34(5):418-20. PubMed ID: 7788169
[TBL] [Abstract][Full Text] [Related]
22. Serum IgA anti-Klebsiella antibodies in ankylosing spondylitis patients from Catalonia.
Collado A; Gratacós J; Ebringer A; Rashid T; Martí A; Sanmartí R; Muñoz-Gomez J
Scand J Rheumatol; 1994; 23(3):119-23. PubMed ID: 8016581
[TBL] [Abstract][Full Text] [Related]
23. [Antibodies to Klebsiella pneumoniae in ankylosing spondylitis].
Mateicka F; Kozáková D; Cebecauer L; Ondrasík M; Bosmanský K
Cas Lek Cesk; 1989 Jan; 128(5):132-4. PubMed ID: 2676185
[TBL] [Abstract][Full Text] [Related]
24. Serum and secretory IgA immune response to Klebsiella pneumoniae in ankylosing spondylitis.
Trull AK; Panayi GS
Clin Rheumatol; 1983 Dec; 2(4):331-7. PubMed ID: 6430627
[TBL] [Abstract][Full Text] [Related]
25. Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumonia in the pathogenesis of familial ankylosing spondylitis.
Stone MA; Payne U; Schentag C; Rahman P; Pacheco-Tena C; Inman RD
Rheumatology (Oxford); 2004 Feb; 43(2):148-55. PubMed ID: 12949256
[TBL] [Abstract][Full Text] [Related]
26. Klebsiella antibodies in ankylosing spondylitis and Proteus antibodies in rheumatoid arthritis.
Ebringer A; Cox NL; Abuljadayel I; Ghuloom M; Khalafpour S; Ptaszynska T; Shodjai-Moradi F; Wilson C
Br J Rheumatol; 1988; 27 Suppl 2():72-85. PubMed ID: 3042077
[TBL] [Abstract][Full Text] [Related]
27. Similarly increased serum IgA1 and IgA2 subclass antibody levels against Klebsiella pneumoniae bacteria in ankylosing spondylitis patients with/without extra-articular features.
Mäki-Ikola O; Lehtinen K; Granfors K
Br J Rheumatol; 1996 Feb; 35(2):125-8. PubMed ID: 8612022
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis.
Tiwana H; Walmsley RS; Wilson C; Yiannakou JY; Ciclitira PJ; Wakefield AJ; Ebringer A
Br J Rheumatol; 1998 May; 37(5):525-31. PubMed ID: 9651080
[TBL] [Abstract][Full Text] [Related]
29. IgM, IgA and IgG class serum antibodies against Klebsiella pneumoniae and Escherichia coli lipopolysaccharides in patients with ankylosing spondylitis.
Mäki-Ikola O; Lehtinen K; Nissilä M; Granfors K
Br J Rheumatol; 1994 Nov; 33(11):1025-9. PubMed ID: 7981989
[TBL] [Abstract][Full Text] [Related]
30. Cellular immune response to Klebsiella pneumoniae antigens in patients with HLA-B27+ ankylosing spondylitis.
Domínguez-López ML; Cancino-Díaz ME; Jiménez-Zamudio L; Granados-Arreola J; Burgos-Vargas R; García-Latorre E
J Rheumatol; 2000 Jun; 27(6):1453-60. PubMed ID: 10852270
[TBL] [Abstract][Full Text] [Related]
31. Enterobacterial antibodies in Chinese patients with rheumatoid arthritis and ankylosing spondylitis.
Chou CT; Uksila J; Toivanen P
Clin Exp Rheumatol; 1998; 16(2):161-4. PubMed ID: 9536392
[TBL] [Abstract][Full Text] [Related]
32. Immunoblot analysis of antibody response to Chlamydia trachomatis in patients with reactive arthritis and ankylosing spondylitis.
Kihlström E; Grönberg A; Bengtsson A
Scand J Rheumatol; 1989; 18(6):377-83. PubMed ID: 2617227
[TBL] [Abstract][Full Text] [Related]
33. Serum IgA to enterobacteria in ankylosing spondylitis.
van Bohemen CG; Nabbe AJ; Goei The HS; Mazurkiewicz ES; van der Linden S; Zanen HC
Scand J Rheumatol; 1986; 15(3):305-9. PubMed ID: 3541170
[TBL] [Abstract][Full Text] [Related]
34. Elisa studies in ankylosing spondylitis.
Panayi GS
Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):119-21. PubMed ID: 6652391
[TBL] [Abstract][Full Text] [Related]
35. Proteus mirabilis and rheumatoid arthritis: no association with the disease.
Chandrashekara S; Ramesh MN; Shobha A; Saravanan Y; Vadiraja HS; Navaneeth BV; Sandhya Belwadi MR
Clin Rheumatol; 2003 Oct; 22(4-5):268-70. PubMed ID: 14576988
[TBL] [Abstract][Full Text] [Related]
36. The detection of raised levels of IgM to Proteus mirabilis in sera from patients with rheumatoid arthritis.
Senior BW; McBride PD; Morley KD; Kerr MA
J Med Microbiol; 1995 Sep; 43(3):176-84. PubMed ID: 7650724
[TBL] [Abstract][Full Text] [Related]
37. Evidence that patients with rheumatoid arthritis have asymptomatic 'non-significant' Proteus mirabilis bacteriuria more frequently than healthy controls.
Senior BW; Anderson GA; Morley KD; Kerr MA
J Infect; 1999 Mar; 38(2):99-106. PubMed ID: 10342649
[TBL] [Abstract][Full Text] [Related]
38. Selective IgA immune unresponsiveness to Proteus mirabilis fumarate reductase A-chain in rheumatoid arthritis.
Weisbart RH; Min Y; Wong AL; Kang J; Kwunyeun S; Lin A; Kim J; Chan G; Wakelin R; Sohn W; Chang SS; Nishimura RN
J Rheumatol; 2005 Jul; 32(7):1208-12. PubMed ID: 15996053
[TBL] [Abstract][Full Text] [Related]
39. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
[TBL] [Abstract][Full Text] [Related]
40. The potential use of antibacterial peptide antibody indices in the diagnosis of rheumatoid arthritis and ankylosing spondylitis.
Rashid T; Ebringer A; Wilson C; Bansal S; Paimela L; Binder A
J Clin Rheumatol; 2006 Feb; 12(1):11-6. PubMed ID: 16484874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
